| NCT Number | NCT07631793 |
| Lead Sponsor | Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. |
| Conditions | Malignant Neoplasms |
| Enrollment | 76 participants |
| Start Date | 2026-05-30 |
| Primary Completion | 2027-12-08 (estimated) |
| Study Completion | 2030-12-07 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-08 |